The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Chardan Capital: Maintaining a "buy" rating on Senti Biosciences ( Senti Biosciences Holdings Inc(SNTI.US) ), while raising the price target from $11 to $12.

Ladenburg Thalmann: Maintaining a "buy" rating on Usio ( USIO INC(USIO.US) ), while raising the price target from $5.75 to $6.25.

RBC Capital: Maintaining its "Outperform Market" rating for MeiraGTx Holdings ( MEIRAGTX HOLDINGS PLC(MGTX.US) ), while raising its price target from $24 to $25.

Ladenburg Thalmann: Initial rating for Cellectar Biosciences ( Cellectar Biosciences(CLRB.US) ) stock at "Buy", with a target price of $10.

Oppenheimer: Maintaining Veru's ( Veru Inc(VERU.US) ) rating at "Outperform Market", while lowering the price target from $25 to $24.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
Senti Biosciences Holdings Inc(SNTI.US)	to lift	$12.0	$1.01	1088.12%	Chardan Capital
USIO INC(USIO.US)	to lift	$6.25	$1.52	311.18%	Ladenburg Thalmann
MEIRAGTX HOLDINGS PLC(MGTX.US)	to lift	$25.0	$9.4	165.96%	RBC Capital
Kyverna Therapeutics, Inc.(KYTX.US)	to lift	$25.0	$9.49	163.44%	HC Wainwright & Co.
Anteris Technologies Global Corp.(AVR.US)	to lift	$18.0	$7.24	148.62%	Barclays
Cellectar Biosciences(CLRB.US)	Initial classification	$10.0	$3.09	223.62%	Ladenburg Thalmann
Veru Inc(VERU.US)	cut	$24.0	$2.11	1037.44%	Oppenheimer
HeartBeam(BEAT.US)	cut	$5.0	$0.965	418.13%	Benchmark
Jasper Therapeutics, Inc.(JSPR.US)	cut	$3.0	$0.8501	252.9%	RBC Capital
Mobile Infrastructure Corp(BEEP.US)	cut	$6.0	$1.91	214.14%	Maxim Group

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Keybanc: Maintaining an "overweight" rating on Applied Materials ( Applied Materials, Inc.(AMAT.US) stock, while raising the price target from $450 to $550.

Needham: Maintaining a "buy" rating on Applied Materials Applied Materials, Inc.(AMAT.US) ) stock, while raising the price target from $440 to $530.

TD Cowen: Maintaining a "buy" rating on Broadcom Limited(AVGO.US) ), raising its price target from $405 to $500.

Oppenheimer: Maintaining Google-C's ( Alphabet Inc. Class C(GOOG.US) ) rating at "Outperforming the Market," while raising the price target from $425 to $445.

TD Cowen: Maintaining a "Hold" rating on Marvell Technology ( Marvell Technology, Inc.(MRVL.US) ), while raising the price target from $90 to $190.

Guggenheim: Maintaining a "buy" rating on Madison Square Garden ( Madison Square Garden Co. Class A(MSGS.US) ), while raising the price target from $401 to $422.

Citigroup: Maintaining a "buy" rating on Nebius Group ( NEBIUS(NBIS.US) ), while raising its price target from $169 to $287.

TD Cowen: Maintaining a "buy" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $235 to $275.

Oppenheimer: Maintaining Palo Alto Networks’ Palo Alto Networks, Inc.(PANW.US) ) rating at “Outperform Market”, while raising the price target from $245 to $275.

RBC Capital: Maintaining Vertiv Holdings' ( VERTIV HOLDINGS LLC(VRT.US) ) rating at "Outperforming Market", while raising the price target from $356 to $435.

First Coverage

Ladenburg Thalmann: Initial rating for Cellectar Biosciences ( Cellectar Biosciences(CLRB.US) ) stock at "Buy", with a target price of $10.

DA Davidson: Initial rating for Eastern Bankshares ( Eastern Bankshares, Inc(EBC.US) ) at "Buy", with a target price of $24.

Piper Sandler: Initial rating for The Estée Lauder Companies ( Estee Lauder Companies Inc. Class A(EL.US) ) stock at "overweight", with a target price of $95.

Wedbush: Solventum Corporation ( Solventum Corporation(SOLV.US) stock has an initial rating of "outperforming the market", with a price target of $94.

reduction

Citigroup: Maintaining a "buy" rating on Lucid Group ( Lucid(LCID.US) ) stock, while lowering the price target from $17 to $14.

Citigroup: Downgraded Optimum Communications ( Optimum Communications, Inc. Class A(OPTU.US) ) stock to "Sell," lowering its price target from $1.50 to $0.50.

Canaccord Genuity: Maintains its "Buy" rating on Prestige Consumer ( Prestige Consumer Healthcare Inc(PBH.US) ), while lowering its price target from $86 to $72.

JP Morgan: Maintaining PCG's ( PG&E Corporation(PCG.US) ) rating at "overweight", while lowering the price target from $24 to $23.

Wells Fargo: Downgraded Wix.com ( Wix.com Ltd.(WIX.US) ) stock to "market-weighted", with a price target cut from $137 to $54.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.